memori
popul
import
protect
subsequ
infect
divers
receptor
tcr
repertoir
also
intrins
tcr
cell
discrimin
peptid
usual
eight
amino
acid
embed
major
histocompat
complex
class
molecul
crystal
structur
studi
reveal
tcr
contact
residu
peptid
present
mhc
molecul
requir
activ
although
tcr
toler
certain
amino
acid
substitut
peptid
sequenc
still
becom
activ
exampl
amino
acid
substitut
human
leukocyt
antigen
hla
epstein
barr
viru
ebv
peptid
posit
toler
substitut
posit
crucial
cytotox
recognit
thu
molecular
mimicri
wherebi
peptid
ligand
differ
origin
ligand
retain
site
necessari
interact
tcr
one
sever
path
respons
howev
altern
explan
flexibl
tcr
bind
may
explain
thermodynam
studi
tcr
peptid
mhc
interact
tcr
undergo
conform
chang
tcr
complementar
determin
region
proper
accommod
cognat
antigen
seen
human
cell
bind
epitop
mous
cell
bind
cytochrom
c
epitop
wu
et
al
suggest
induc
fit
model
low
conform
complementar
first
contact
mhc
molecul
via
loop
follow
readjust
flexibl
loop
peptid
mhc
complex
flexibl
molecul
lead
enhanc
abil
singl
tcr
accommod
structur
divers
peptid
possibl
kinet
flexibl
tcr
may
also
lead
differ
region
tcr
interact
differ
site
two
separ
ligand
term
altern
recognit
anoth
mechan
abil
cell
express
two
differ
tcr
due
incomplet
allel
exclus
chain
mathemat
calcul
suggest
singl
tcr
abl
react
differ
nonam
peptid
taken
togeth
mechan
make
difficult
predict
fairli
common
event
may
valuabl
host
consid
larg
number
potenti
pathogen
antigen
one
expos
lifetim
could
compens
situat
limit
tcr
repertoir
still
allow
normal
immun
respons
instanc
mice
defici
enzym
termin
deoxynucleotidyl
transferas
tdt
impair
diversif
tcr
repertoir
calcul
wildtyp
mice
upon
lymphocyt
choriomening
viru
lcmv
sendai
viru
infect
mice
rel
normal
immun
respons
recov
infect
mice
report
cell
highli
profil
compar
wildtyp
mice
thu
may
compens
less
divers
tcr
repertoir
addit
mani
tcr
transgen
mice
limit
tcr
divers
capabl
respond
mani
antigen
resist
viral
infect
report
memori
cell
recogn
epitop
differ
protein
pathogen
protein
close
relat
total
unrel
pathogen
increas
review
perhap
surpris
respons
seen
direct
evolutionarili
conserv
site
within
viru
group
differ
strain
influenza
viru
dengu
viru
conserv
site
differ
member
viru
group
hantavirus
arenavirus
flavivirus
howev
exampl
respons
involv
complet
unrel
virus
lcmv
vaccinia
viru
vv
influenza
viru
hepat
c
viru
hcv
influenza
viru
ebv
influenza
viru
human
immunodefici
viru
hiv
human
papillomaviru
coronaviru
shown
respons
frequent
observ
memori
popul
gener
due
increas
frequenc
higher
activ
state
memori
cell
immun
respons
present
alter
dynam
consider
consequ
pathogenesi
infect
either
inhibit
enhanc
replic
newli
encount
heterolog
viru
also
signific
impact
allospecif
activ
prior
follow
transplant
addit
autoimmun
associ
viral
infect
like
individu
histori
viru
infect
uniqu
composit
memori
pool
may
either
initi
reactiv
cell
potenti
although
hundr
peptid
viral
infect
appropri
sequenc
bind
usual
small
number
epitop
stimul
immunogen
respons
memori
pool
creat
viru
infect
distinct
hierarchi
respons
host
viral
epitop
domin
stimul
high
frequenc
respons
other
subdomin
stimul
weaker
bare
detect
respons
immunodomin
hierarchi
regul
variou
paramet
includ
effici
process
present
peptid
affin
peptid
avail
cell
tcr
recogn
complex
competit
cell
domain
cell
apc
mani
respons
distinct
tcr
amino
acid
motif
maintain
clonotyp
differ
individu
exampl
human
influenza
respons
amino
acid
motif
irss
common
respons
mice
sxg
first
three
posit
region
common
motif
bind
motif
identifi
includ
murin
nucleoprotein
np
respons
gxxn
lcmv
infect
hiv
env
respons
gqg
conserv
amino
acid
motif
suggest
site
requir
tcr
bind
mhc
ligand
structur
similar
usag
amino
acid
motif
well
conserv
immunodomin
hierarchi
thought
public
specif
respons
similar
individu
despit
public
specif
respons
tremend
divers
tcr
repertoir
individu
tcr
usag
per
epitop
differ
individu
host
even
though
might
gener
similar
prefer
tcr
usag
specif
amino
acid
motif
thu
tcr
clone
uniqu
individu
uniqu
region
refer
privat
specif
respons
variat
probabl
consequ
random
stochast
process
tcr
rearrang
thymu
result
variat
peripher
tcr
repertoir
random
stochast
process
wherebi
encount
apc
present
cognat
ligand
clone
stimul
earli
may
domin
respons
interf
stimul
cell
memori
specif
epitop
unrel
pathogen
high
frequenc
activ
state
memori
cell
give
advantag
cell
lead
preferenti
expans
popul
expans
alter
hierarchi
respons
saw
sequenti
heterolog
viru
infect
mice
two
distantli
relat
arenavirus
lcmv
pichind
viru
pv
virus
encod
epitop
six
eight
amino
acid
common
epitop
normal
subdomin
either
viru
host
howev
due
select
expans
memori
cell
respons
becam
domin
mice
infect
pv
mice
infect
lcmv
data
support
concept
expans
popul
substanti
contribut
immun
hierarchi
respons
studi
may
explain
variabl
immunodomin
hierarchi
observ
human
viral
infect
host
expos
numer
infect
throughout
life
instanc
patient
ident
haplotyp
infect
hiv
hcv
show
high
variabl
immun
hierarchi
interestingli
respons
pathogen
document
virus
studi
vv
infect
mice
show
vv
sometim
elicit
expans
cell
one
lcmv
epitop
specif
time
elicit
expans
cell
differ
specif
outcom
could
explain
stochast
natur
clonal
domin
privat
specif
tcr
repertoir
immun
host
thu
proport
memori
cell
anoth
antigen
would
differ
host
host
variat
inde
observ
host
challeng
vv
studi
predict
epitop
might
drive
respons
vv
substanti
variabl
note
individu
mice
test
mice
vv
infect
stimul
strong
expans
cell
specif
lcmv
epitop
mice
specif
either
glycoprotein
gp
overlap
epitop
mice
specif
epitop
fig
often
expans
cell
specif
one
lcmv
epitop
sometim
cell
specif
one
epitop
expand
question
whether
variat
expans
repres
random
stochast
event
mous
challeng
vv
limit
number
cell
actual
engag
antigen
whether
mous
uniqu
repertoir
regard
potenti
vv
address
point
carboxyfluorescein
succinimidyl
ester
csfe
splenocyt
differ
donor
mice
adopt
transfer
three
recipi
challeng
vv
pattern
expans
virtual
ident
among
recipi
singl
donor
differ
recipi
differ
donor
result
show
variat
respons
reflect
privat
specif
individu
immun
host
although
high
level
involv
two
lcmv
pv
epitop
regard
product
heterolog
viru
challeng
select
small
subset
cell
lead
substanti
narrow
tcr
repertoir
narrow
repertoir
differ
pattern
individu
adopt
transfer
studi
indic
variat
reflect
privat
specif
immun
system
develop
primari
infect
studi
except
link
narrow
tcr
repertoir
poor
viral
clearanc
enhanc
probabl
select
epitop
escap
variant
thu
privat
specif
memori
tcr
repertoir
add
anoth
level
complex
understand
respons
explain
variabl
diseas
outcom
upon
infect
pathogen
memori
cell
heterolog
viru
provid
partial
protect
immun
experiment
model
provid
differ
life
death
infect
host
tabl
exampl
mice
control
pv
infect
presum
due
cell
specif
subdomin
epitop
mice
also
manifest
strong
protect
immun
infect
larg
dna
poxviru
vv
compar
mice
respiratori
model
infect
heterolog
immun
prevent
mortal
otherwis
lethal
dose
vv
adopt
transfer
studi
demonstr
cell
mice
requir
transfer
protect
immun
mice
challeng
pv
vv
tenuou
balanc
immunodomin
protect
immun
immunopatholog
heterolog
immun
alway
benefici
although
immun
lcmv
protect
respiratori
vv
infect
inhibit
clearanc
respiratori
syncyti
viru
rsv
similarli
work
demonstr
histori
influenza
infect
protect
vv
inhibit
clearanc
murin
cytomegaloviru
mcmv
lcmv
tabl
although
lcmv
immun
protect
vv
immun
vv
protect
lcmv
correspondingli
although
vv
elicit
prolifer
subset
adopt
transfer
lcmv
memori
cell
lcmv
stimul
littl
prolifer
popul
sinc
vv
encod
protein
perhap
thousand
potenti
epitop
probabl
much
like
encod
epitop
would
activ
cell
popul
wherea
lcmv
encod
four
protein
far
limit
number
epitop
may
less
like
encount
stimul
find
could
explain
mani
larg
dna
virus
evolv
encod
gene
product
interfer
antigen
present
factor
may
also
involv
instanc
vv
might
better
induc
lcmv
could
lead
enhanc
product
cell
select
expans
memori
cell
upon
vv
infect
suggest
possibl
respons
two
virus
base
concept
molecular
mimicri
identifi
epitop
search
vv
sequenc
homolog
lcmv
epitop
fig
epitop
gener
respons
highli
three
memori
respons
incident
show
one
respons
anoth
vv
respons
unpublish
data
henc
whole
matrix
reveal
one
vv
epitop
could
activ
five
differ
memori
popul
impact
heterolog
immun
signific
howev
cell
line
deriv
individu
donor
line
differ
pattern
high
one
epitop
other
high
differ
epitop
reflect
privat
specif
unpublish
data
cell
mediat
protect
immun
also
substanti
immunopatholog
lcmv
infect
cell
clear
viru
also
mediat
sever
leptomening
patholog
acut
infect
like
result
inflammatori
condit
induc
presenc
high
number
cell
lyse
infect
tissu
produc
cytokin
chemokin
recruit
cell
diseas
outcom
ultim
base
fine
balanc
number
memori
cell
recruit
site
viral
replic
effici
length
time
cell
present
amplifi
respons
viru
clear
effici
activ
cell
viral
clearanc
least
partial
depend
avid
tcr
interact
ligand
studi
alter
peptid
ligand
apl
repres
vitro
model
respons
show
ligand
differ
length
time
tcr
interact
mhcligand
ie
tcr
avid
modifi
function
potenti
individu
clone
studi
help
explain
lower
avid
respons
may
protect
well
heterolog
viru
heterolog
immun
may
effect
mediat
protect
immun
homolog
immun
easi
imagin
enhanc
earli
activ
lower
avid
clone
might
ineffici
protect
could
lead
differ
type
immunopatholog
exampl
balanc
immun
patholog
seen
vv
infect
mice
mice
challeng
vv
develop
pannicul
present
necrosi
viscer
fat
analog
human
erythema
nodosum
respiratori
infect
model
reduc
mortal
mice
infect
vv
accompani
alter
lung
patholog
lung
infiltr
cell
contribut
obstruct
bronchiol
fibrin
inflammatori
cell
bronchiol
obliteran
human
erythema
nodosum
bronchiol
obliteran
unknown
etiolog
seen
viral
bacteri
infect
also
associ
autoimmun
diseas
erythema
nodosum
observ
vaccin
smallpox
hepat
b
develop
bronchiol
obliteran
lung
allograft
associ
transplant
reject
alter
patholog
also
occur
mice
augment
viral
replic
upon
lcmv
mcmv
infect
instead
usual
mild
mononuclear
infiltr
observ
acut
mcmv
infect
mice
mice
infect
mcmv
develop
sever
consolid
mononuclear
pneumonia
evid
bronchiol
bronchiol
alveolar
epithelium
replac
cell
indic
lung
repair
manifest
heterolog
immun
may
therefor
explain
variat
human
diseas
pathogenesi
thought
previous
affect
genet
differ
physiolog
condit
patient
inocul
rout
dose
individu
histori
infect
may
shape
memori
pool
way
contribut
variabl
heterolog
immun
respons
reminisc
phenomenon
origin
antigen
sin
first
describ
respons
influenza
viru
subtyp
differ
strain
variant
influenza
viru
commonli
level
mice
human
lead
specul
cell
may
involv
pathogenesi
influenza
viru
infect
perhap
recogn
human
exampl
heterolog
immun
come
dengu
viru
infect
infect
dengu
viru
serotyp
gener
cell
higher
avid
second
presum
previous
encount
dengu
viru
serotyp
suggest
memori
cell
preferenti
expand
cell
greater
avid
serotyp
caus
infect
lower
avid
cell
may
mediat
sever
diseas
outcom
includ
hemorrhag
fever
observ
subsequ
infect
differ
dengu
viru
serotyp
differ
clinic
asymptomat
acut
ebv
infect
magnitud
respons
viral
load
symptomat
diseas
form
acut
infecti
mononucleosi
syndrom
less
like
young
children
teenag
young
adult
longer
histori
infect
presum
complex
pool
memori
cell
young
children
infect
follow
similar
pattern
includ
mump
chicken
pox
polio
measl
subset
cell
direct
major
immunodomin
ebv
epitop
invari
influenza
viru
epitop
even
though
share
three
nine
amino
acid
recent
studi
shown
activ
cell
acut
mononucleosi
patient
perhap
reflect
privat
specif
host
respons
due
larg
size
genom
ebv
like
present
extens
pool
potenti
epitop
could
activ
memori
cell
differ
specif
fact
abl
defin
matrix
ebv
influenza
viru
epitop
analog
vvlcmv
matrix
center
ebv
epitop
unpublish
data
fig
analys
tcr
repertoir
two
individu
experienc
acut
infecti
mononucleosi
howev
reveal
substanti
differ
hierarchi
usag
healthi
influenza
immun
donor
suggest
skew
subset
tcr
repertoir
probabl
ebv
stimul
prolifer
interestingli
cell
apl
studi
behav
differ
function
respons
ligand
cell
bound
tetram
produc
tumor
necrosi
factor
macrophag
inflammatori
protein
ligand
bound
one
tetram
produc
altern
ligand
bound
one
tetram
abl
produc
altern
ligand
would
appear
interact
altern
ligand
highli
variabl
function
pattern
inde
heterogen
henc
multipl
techniqu
requir
detect
includ
tetram
stain
differ
function
assay
potenti
import
factor
tcr
interact
ligand
tcr
avid
interact
altern
ligand
could
weak
stabli
bind
tetram
could
suffici
induc
distinct
hierarchi
cytokin
product
analog
observ
influenza
clone
unabl
bind
tetram
produc
follow
peptid
stimul
extrem
variabl
pathogenesi
hcv
human
rang
asymptomat
fulmin
steril
persist
infect
heterolog
immun
may
play
role
variabl
hcv
encod
epitop
share
six
eight
amino
acid
influenza
epitop
cell
individu
evid
past
hcv
infect
often
respond
hcv
epitop
vitro
henc
human
popul
may
partial
immun
hcv
consequ
pronounc
respons
influenza
hcv
note
patient
hcv
infect
result
narrow
repertoir
singl
epitop
patient
experienc
fulmin
necrot
hepat
far
sever
patient
mount
divers
respons
patient
would
like
immun
ubiquit
influenza
viru
suggest
privat
specif
may
dictat
alter
immun
respons
immun
previous
encount
virus
alter
cytokin
respons
subsequ
viru
encount
prior
immun
lcmv
induc
much
higher
level
lower
level
upon
vv
infect
much
enhanc
product
come
directli
lcmv
cell
activ
vv
infect
immun
influenza
protect
mice
sever
diseas
caus
infect
rsv
rsv
vaccin
shift
usual
respons
respons
prevent
sever
eosinophil
infiltr
lung
chang
respons
due
infect
vaccin
earli
childhood
might
explain
children
like
develop
allergi
other
sever
studi
report
benefici
effect
earli
infect
childhood
develop
asthma
may
consequ
earli
skew
memori
pool
toward
phenotyp
would
inhibit
allerg
respons
repertoir
contain
larg
number
allospecif
cell
may
recruit
respons
frequenc
allospecif
cell
estim
rang
total
cell
use
limit
dilut
cell
outgrowth
techniqu
howev
protocol
optim
quantif
directli
ex
vivo
requir
lengthi
period
vitro
cultur
may
accur
reflect
frequenc
allospecif
cell
vivo
recent
intracellular
cytokin
assay
util
detect
allospecif
cell
effici
directli
ex
vivo
adopt
cytokin
assay
specif
identifi
cell
cell
previous
thought
acquir
effector
function
undergo
differenti
process
demonstr
cell
rapidli
produc
follow
tcr
engag
vitro
use
product
marker
allospecif
cell
readili
detect
directli
ex
vivo
frequenc
rang
total
cell
allospecif
cell
distinguish
effectormemori
allospecif
cell
differenti
product
effectormemori
cell
produc
cytokin
unpublish
data
natur
antigen
recognit
cell
suggest
allospecif
cell
may
activ
viral
infect
initi
result
laboratori
demonstr
acut
infect
mice
lcmv
stimul
allospecif
cytotox
broad
rang
foreign
haplotyp
vitro
kill
allogen
target
cell
detect
seven
day
infect
primarili
mediat
cell
allospecif
cell
activ
infect
lcmv
also
detect
product
respons
allogen
target
infect
mice
virus
includ
pv
vv
mcmv
also
stimul
allospecif
cytotox
suggest
gener
phenomenon
follow
infect
cytotox
allospecif
cell
also
found
human
infect
ebv
acut
infecti
mononucleosi
heterolog
immun
import
mechan
activ
allospecif
cell
follow
infect
virus
alloantigen
demonstr
numer
infect
model
clone
deriv
mice
infect
lcmv
influenza
viru
vsv
human
infect
ebv
herp
simplex
viru
studi
examin
cell
alloantigen
show
portion
cell
specif
four
lcmv
epitop
examin
antigen
determin
product
howev
antigen
broad
also
distinct
differ
proport
popul
recogn
allogen
target
distinct
natur
clearli
evid
cell
antigen
still
also
select
two
four
examin
result
suggest
viral
infect
dramat
alter
repertoir
unexpect
manner
activ
allospecif
cell
infect
may
account
presenc
allospecif
cell
memori
phenotyp
individu
previous
expos
alloantigen
inde
acut
lcmv
infect
resolv
memori
phenotyp
allospecif
cell
remain
present
rest
immun
state
activ
allospecif
cell
viral
infect
may
import
consequ
transplant
foreign
tissu
mainten
graft
function
viral
infect
demonstr
rapidli
induc
reject
allogen
splenocyt
implant
mice
studi
fate
allogen
cell
implant
mice
monitor
use
vivo
cytotox
assay
assay
allow
reject
allogen
splenocyt
examin
vivo
within
h
transfer
vivo
cytotox
assay
also
detect
natur
killer
nk
reject
allogen
splenocyt
specif
examin
mechan
nk
cell
need
deplet
transfer
target
splenocyt
infect
mice
either
lcmv
pv
induc
mechan
reject
implant
allogen
splenocyt
first
detect
one
day
infect
reach
peak
level
day
three
postinfect
reject
surpris
occur
earli
time
point
infect
nk
cell
function
peak
outcom
could
either
due
allospecif
cell
viral
antigen
due
vigor
primari
respons
implant
allogen
cell
wake
rich
cytokin
environ
creat
acut
infect
tradit
method
prolong
surviv
allogen
tissu
graft
involv
use
chronic
immunosuppress
prevent
gener
immun
respons
use
costimul
blockad
toler
cell
specif
donor
tissu
proven
promis
altern
approach
achiev
surviv
transplant
tissu
without
need
gener
immunosuppress
howev
recent
studi
demonstr
acut
viral
infect
serious
diminish
efficaci
protocol
acut
infect
mice
virus
lcmv
pv
within
day
persist
infect
lcmv
interf
induct
toler
alloantigen
result
rapid
reject
allogen
skin
graft
deplet
cell
recipi
mice
significantli
delay
reject
skin
allograft
support
role
cell
mediat
reject
inabl
poli
c
vv
mcmv
abrog
toler
condit
suggest
product
cytokin
alon
suffici
induc
reject
mechan
mediat
abrog
transplant
toler
still
remain
clarifi
though
could
involv
although
disrupt
toler
evid
time
point
transplant
mice
treat
receptor
tlr
agonist
poli
c
lipopolysaccharid
prior
transplant
allogen
tissu
effect
toler
suggest
earli
stage
toler
induct
sensit
mechan
find
suggest
ongo
viral
infect
impedi
use
costimul
blockad
induct
toler
human
presenc
memori
allospecif
cell
associ
acceler
reject
allogen
tissu
transplant
recipi
memori
allospecif
cell
gener
exposur
alloantigen
also
refractori
effect
costimul
blockad
memori
cell
less
reliant
costimulatori
signal
activ
memori
allospecif
cell
gener
infect
also
refractori
costimul
blockad
mice
previous
infect
lcmv
possess
memori
phenotyp
allospecif
cell
suffici
toler
costimul
blockad
accept
allogen
skin
graft
moreov
sequenti
infect
mice
heterolog
virus
gener
higher
frequenc
allospecif
memori
cell
increas
resist
costimul
blockad
result
suggest
individu
histori
infect
influenc
respons
histori
import
factor
design
novel
methodolog
achiev
optim
graft
surviv
human
due
larg
complex
memori
popul
number
regul
ratio
cell
divis
cell
death
usual
occur
apoptosi
import
distinguish
concept
cell
divis
cell
prolifer
latter
mean
increas
cell
number
divis
may
occur
without
increas
cell
number
case
homeostasi
divid
cell
may
becom
sensit
variou
type
proapoptot
stimuli
divis
must
overcom
apoptosi
result
increas
number
dynam
cell
number
chang
lcmv
infect
mice
display
fig
initi
signific
loss
number
earli
stage
lcmv
mani
viral
infect
mice
human
expans
phase
cell
follow
divis
outpac
apoptosi
next
contract
silenc
phase
number
spleen
lymph
node
declin
apoptosi
migrat
peripher
tissu
paramet
respons
similar
mous
human
mani
viral
infect
mous
human
induc
substanti
loss
lymphocyt
leukocyt
number
earli
stage
infect
undoubtedli
may
mani
mechan
loss
cell
number
common
mediat
may
type
ifn
induc
high
level
earli
stage
infect
direct
respons
viral
replic
substanti
loss
number
first
five
day
lcmv
infect
parallel
level
type
ifn
product
occur
type
ifn
receptor
knockout
mice
block
antibodi
type
ifn
mimick
tlr
agonist
poli
c
cell
suffer
highest
level
apoptosi
cell
cell
activ
caspas
express
phosphatidyl
serin
membran
interact
annexin
v
apoptot
loss
either
memori
lesser
extent
cell
occur
prior
cell
divis
shown
bromodeoxyuridin
uptak
studi
vivo
implant
cell
mice
look
loss
csfe
stain
indic
cell
divis
versu
apoptosi
earli
apoptosi
cell
inhibit
stimul
cell
ligand
inject
mice
enough
lcmv
epitop
caus
activ
transgen
memori
cell
vivo
regard
inhibit
poli
c
apoptosi
cell
find
interest
model
activ
indic
exposur
cell
ligand
especi
context
proper
costimul
caus
upregul
antiapoptot
factor
protect
divid
cell
apoptosi
comput
model
howev
indic
without
apoptosi
memori
cell
earli
stage
infect
cell
might
domin
respons
infect
select
reduc
frequenc
memori
cell
begin
immun
respons
may
highli
divers
respons
new
pathogen
high
divers
may
benefici
pathogen
control
type
ifn
appear
play
number
role
earli
stage
respons
major
effect
differenti
dendrit
cell
act
somewhat
surprisingli
signal
transduc
activ
transcript
pathway
recent
work
growth
inhibitori
function
type
ifn
might
link
properti
implic
import
signal
pathway
interest
cell
downregul
activ
becom
resist
growth
inhibitori
effect
ifn
type
ifn
also
induc
divis
memori
cell
abil
induc
memori
cell
express
receptor
also
mediat
homeostat
divis
togeth
seem
type
ifn
first
caus
apoptosi
memori
cell
gener
lymphopen
state
stimul
divid
lymphopen
state
correct
overshoot
number
unless
antigen
drive
new
immun
respons
peak
respons
activ
cell
spleen
lymph
node
express
elev
level
fa
fa
ligand
fasl
becom
suscept
cell
death
aicd
express
preapoptot
phenotyp
indic
stain
annexin
v
maintain
function
cytotox
cytokin
product
controversi
concern
whether
stain
annexin
v
realli
mean
impend
apoptosi
whether
might
marker
activ
studi
show
fate
annexin
v
cell
introduc
cultur
vitro
fragment
dna
complet
apoptot
process
transfer
mice
vivo
annexin
v
cell
popul
gradual
decreas
number
fail
mediat
recal
respons
wherea
similarli
transfer
annexin
cell
could
mediat
recal
respons
correl
made
cell
annexin
express
receptor
express
cell
bear
high
concentr
antiapoptot
marker
precursor
fulli
function
memori
cell
thu
feel
annexin
v
inde
harbing
apoptosi
though
apoptosi
necessarili
happen
immedi
part
silenc
phase
associ
dissemin
cell
spleen
lymph
node
peripher
organ
commonli
state
activ
cell
die
apoptosi
number
base
examin
frequenc
lymphoid
tissu
one
studi
influenza
system
indic
much
smaller
reduct
cell
bodi
ad
featur
cell
peripheri
mean
lung
viscer
fat
periton
caviti
differ
apoptot
phenotyp
present
spleen
lymph
node
time
peripher
cell
react
less
annexin
v
express
stain
less
antibodi
fa
fasl
rel
resist
aicd
lcmv
system
part
resist
periton
cell
aicd
link
presenc
transform
growth
lung
mice
resist
apoptosi
link
collagen
lung
signal
integrin
express
cell
signal
certain
integrin
adhes
molecul
long
known
render
cell
resist
apoptosi
chang
tissu
environ
cell
may
well
alter
apoptot
properti
signific
find
may
relat
fact
effector
memori
cell
may
linger
peripher
tissu
long
clearanc
viru
provid
potenti
fast
act
line
defens
pathogen
intrigu
aspect
apoptosi
cell
prefer
regard
degre
apoptosi
easili
seen
lcmv
infect
mice
cell
specif
epitop
express
higher
annexin
v
reactiv
higher
fa
lower
higher
mitochondri
membran
potenti
cell
specif
epitop
find
might
explain
fact
cell
specif
epitop
may
trigger
often
epitop
lcmv
np
express
much
higher
level
gp
lcmv
infect
cell
howev
vv
recombin
express
np
versu
similar
promot
stimul
cell
apoptot
properti
nevertheless
epitop
high
affin
binder
may
still
express
better
intrigu
howev
differenti
apoptosi
also
seen
secondari
immun
would
less
antigen
present
rest
immun
state
antigen
apoptot
level
lower
rest
immun
state
apoptot
differenti
versu
cell
remain
seem
apoptot
properti
cell
intrins
properti
epitop
presum
learn
earli
phase
infect
imprint
perman
cell
one
might
expect
ratio
cell
chang
rest
memori
state
inde
moder
shift
domin
time
within
otherwis
moder
stabl
memori
popul
caveat
subtl
shift
hierarchi
cell
differ
apoptot
properti
studi
infect
lcmv
pv
vv
mcmv
vsv
indic
memori
gener
quit
stabl
well
year
significantli
reduc
subsequ
infect
heterolog
virus
littl
inform
avail
concern
stabil
memori
human
studi
done
persist
viru
infect
hiv
ebv
cmv
hcv
repeatedli
encount
pathogen
like
influenza
viru
recent
studi
individu
immun
vv
small
pox
vaccin
indic
rel
stabl
memori
popul
sever
decad
though
memori
frequenc
declin
necessari
determin
whether
repertoir
remain
stabl
time
assess
stabl
memori
studi
mous
suggest
vv
may
highli
virus
invit
possibl
cell
may
maintain
fig
loss
memori
subsequ
infect
also
clarifi
human
infect
larger
immun
system
human
may
abl
accommod
larg
pool
new
memori
cell
without
exclud
other
somewhat
stabl
frequenc
assum
cell
maintain
might
argu
loss
memori
major
issu
human
infect
howev
infect
drive
memori
loss
mice
major
system
infect
caus
substanti
lymphopenia
splenomegali
one
might
expect
substanti
memori
loss
occur
frequent
children
rather
adult
mani
diseas
natur
propos
two
model
explain
loss
memori
occur
consequ
heterolog
viral
infect
activ
attrit
model
wherebi
someth
directli
kill
memori
cell
passiv
attrit
model
newli
form
memori
cell
compet
previous
form
memori
cell
protect
nich
spleen
lymph
node
immun
respons
contract
although
mechan
might
influenc
surviv
memori
data
support
activ
model
occur
earli
lymphopenia
phase
infect
quantifi
memori
cell
follow
frequenc
cours
infect
clear
number
go
earli
lymphopenia
recoveri
rather
modest
may
still
accommod
issu
compet
protect
nich
later
infect
rel
import
seem
less
activ
attrit
model
infect
lymphopenia
commonli
describ
event
occur
mani
human
infect
includ
influenza
west
nile
ebola
hiv
sever
acut
respiratori
syndrom
corona
even
human
lcmv
suspect
factor
drive
attrit
memori
human
littl
analysi
effect
human
lymphopenia
memori
antigen
though
known
patient
receiv
ifn
therapi
least
initi
loss
memori
phenotyp
cell
type
issu
examin
control
vaccin
studi
vaccin
may
drive
level
lymphopenia
necessari
caus
loss
memori
otherwis
vaccine
would
get
sick
issu
may
best
address
mani
volunt
get
bad
reaction
small
pox
vaccin
dynam
greatli
alter
persist
infect
induc
proapoptot
cytokin
also
drive
cell
apoptot
delet
aicd
function
exhaust
studi
shown
memori
cell
specif
heterolog
virus
greatli
delet
initi
infect
high
dose
lcmv
clone
caus
persist
infect
cell
rebound
frequenc
addit
memori
cell
transfer
mice
persist
infect
lcmv
clone
attempt
modest
level
homeostat
divis
rapidli
elimin
similar
mechan
occur
human
would
suggest
persist
infect
hiv
hcv
vigor
delet
memori
everyth
els
receiv
antigen
antigen
persist
human
infect
could
residu
memori
cell
specif
nonpersist
antigen
pathogen
drive
infect
residu
popul
memori
cell
remain
earli
delet
infect
ineffect
restor
popul
frequenc
ineffect
two
reason
first
compet
cell
respond
ongo
infect
prolifer
three
four
divis
per
day
occur
much
higher
rate
homeostat
divis
memori
cell
compet
second
factor
bona
fide
memori
cell
effect
homeostat
prolifer
first
place
even
absenc
infect
splenocyt
transfer
mice
mice
render
lymphopen
irradi
poli
c
inocul
proport
cell
reconstitut
popul
cell
becam
comparison
start
frequenc
substanti
reduc
cell
prolifer
fill
lymphopen
environ
thu
memori
cell
compet
poorli
hp
cell
respond
microbi
flora
predict
condit
human
caus
lymphopenia
infect
irradi
immunosuppress
drug
treatment
induc
memori
cell
loss
need
test
human
well
mice
immun
system
evolv
multipl
divers
memori
tcr
repertoir
accumul
lifetim
new
infect
memori
cell
must
compet
limit
space
competit
least
partial
accomplish
preferenti
loss
prior
memori
popul
activ
mechan
also
memori
cell
specif
previous
encount
pathogen
also
newli
encount
pathogen
preferenti
maintain
expand
repertoir
specif
previou
pathogen
becom
perman
alter
fig
activ
memori
cell
play
role
heterolog
immun
modul
immun
hierarchi
privat
specif
individu
tcr
repertoir
lead
alter
balanc
protect
immun
immunopatholog
respons
also
alter
memori
allospecif
pool
influenc
graft
reject
toler
induct
thu
get
wrong
infect
host
particular
mhc
wrong
time
sequenc
infect
might
signific
consequ
host
understand
fine
balanc
memori
cell
play
induct
protect
immun
versu
patholog
need
learn
consequ
heterolog
immun
respons
work
support
nih
research
grant
dfg
fellowship
